SEC Company Response from AMGEN INC (AMGN) (CIK 0000318154) (AMGN) — Apr 13, 2021
AMGEN INC (AMGN) (CIK 0000318154)
Date: April 13, 2021 · CIK: 0000318154 · Accession: 0001193125-21-114647
AI Filing Summary & Sentiment
File numbers found in text: 333-252898
Letter
Re: Amgen Inc.
April 13, 2021
VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Registration Statement on Form S-4
File No. 333-252898
Acceleration Request
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission (the “Commission”) promulgated under the Securities Act of 1933, as amended, Amgen Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-4 be accelerated to 4:00 p.m., Eastern Time, on Thursday, April 15, 2021, or as soon as practicable thereafter.
There are no underwriters in connection with the registration and, therefore, no request for acceleration or consent by an underwriter has been filed herewith.
The Company requests that it be notified of the effectiveness of the Registration Statement on Form S-4 by telephone call to its counsel Gregory P. Rodgers at (212) 906-2918, followed by written confirmation to the addresses listed on the cover page of the Registration Statement on Form S-4. Thank you for your attention to this matter.
Very truly yours,
AMGEN INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP April 13, 2021 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Amgen Inc. Registration Statement on Form S-4 File No. 333-252898 Acceleration Request Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission (the “Commission”) promulgated under the Securities Act of 1933, as amended, Amgen Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-4 be accelerated to 4:00 p.m., Eastern Time, on Thursday, April 15, 2021, or as soon as practicable thereafter. There are no underwriters in connection with the registration and, therefore, no request for acceleration or consent by an underwriter has been filed herewith. The Company requests that it be notified of the effectiveness of the Registration Statement on Form S-4 by telephone call to its counsel Gregory P. Rodgers at (212) 906-2918, followed by written confirmation to the addresses listed on the cover page of the Registration Statement on Form S-4. Thank you for your attention to this matter. Very truly yours, AMGEN INC. /s/ Justin G. Claeys Justin G. Claeys Vice President, Finance and Treasurer Amgen Inc. cc: Charles K. Ruck Latham & Watkins LLP Gregory P. Rodgers Latham & Watkins LLP